MAP2K7 and cancer: To expand upon genomics analyses and identify potential therapeutic vulnerabilities, reverse phase protein array (RPPA) analysis was performed on laser capture microdissected tumor cells from available trial specimens (69%; 25/36) to map the activated signaling pathway architecture of a number of key cancer related signaling pathways including RAF-MEK-ERK signaling.